Table 1. Comparison of the sensitivity (IC₅₀) of siRNA-CON and siRNA-SLC-2 cell lines to anticancer compounds (n = 3). CI, confidence interval.

siRNA-CON			siRNA-SLC2
IC50 [μM]
Compound	Mean	95% CI	Mean	95% CI	p-value
cisplatin	18.3	15.8–21.2	9.8	8.1–11.7	< 0.0001
dFdC	0.053	0.017–0.161	0.035	0.007–0.168	0.63